Comparing three gels for mild to moderate facial acne
Part of Skin clinical trials.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 40 years old.
- You have mild to moderate acne on your face.
- You have not used any acne cream or pills in the past 2 to 4 weeks.
- You are willing to only use the study gel on your face for 8 weeks.
- You can attend follow-up visits at weeks 2, 4, and 8.
- You are not pregnant or breastfeeding, and have no other skin diseases on your face.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new cleanser and cream combination can safely treat mild to moderate acne. It may help people who have not used other acne treatments recently.
This study tests if metronidazole gel or clindamycin gel works better for people with moderate acne. It aims to find a good treatment option for you.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a new acne cream called clascoterone compared to a standard cream, adapalene, for mild acne. It aims to see which one works better for clearing pimples.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial tests a cream called clascoterone (1%) for people ages 12 and up with moderate to severe facial acne. The cream is applied daily to help reduce pimples and clogged pores.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.